Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Entero Therapeutics | ENTO | Oct 31, 2024 | 0.64 | +4.95 |
Enterprise Bancorp | EBTC | Oct 31, 2024 | 32.11 | -0.06 |
Enterprise Financial Services | EFSC | Oct 31, 2024 | 52.72 | -1.99 |
Enterprise Financial Services A Pref | EFSCP | Oct 31, 2024 | 20.45 | -0.92 |
Enterprise Products Partners LP Unit | EPD | Oct 31, 2024 | 28.66 | -2.05 |
Entrada Therapeutics | TRDA | Oct 31, 2024 | 17.14 | -0.52 |
Entravision Communications | EVC | Oct 31, 2024 | 2.32 | +0.43 |
Envela | ELA | Oct 31, 2024 | 5.26 | -0.57 |
Enveric Biosciences | ENVB | Oct 31, 2024 | 0.50 | -0.60 |
Envestnet | ENV | Oct 31, 2024 | 62.78 | +0.03 |
Enviri | NVRI | Oct 31, 2024 | 7.66 | -23.71 |
Environmental Svcs ETF Market Vectors | EVX | Oct 31, 2024 | 181.27 | -1.56 |
Envirotech Vehicles | EVTV | Oct 31, 2024 | 1.82 | +1.68 |
Envista | NVST | Oct 31, 2024 | 20.97 | +9.05 |
Enviva | EVA | Oct 31, 2024 | 0.42 | 0.00 |
Envoy Medical A | COCH | Oct 31, 2024 | 2.65 | +7.29 |
enVVeno Medical | NVNO | Oct 31, 2024 | 3.37 | +1.81 |
Enzo Biochem | ENZ | Oct 31, 2024 | 1.15 | 0.00 |
EOG Resources | EOG | Oct 31, 2024 | 121.96 | +1.19 |
EON Resources A | EONR | Oct 31, 2024 | 1.25 | 0.00 |
Eos Energy Enterprises | EOSE | Oct 31, 2024 | 3.11 | -9.59 |
EPAM Systems | EPAM | Oct 31, 2024 | 188.65 | -0.24 |
EpicQuest Eduaction Group | EEIQ | Oct 31, 2024 | 0.77 | +2.87 |
ePlus | PLUS | Oct 31, 2024 | 88.95 | -7.06 |
EPR Properties | EPR | Oct 31, 2024 | 45.37 | -4.56 |
EPR Properties Pref C | EPR-C | Oct 31, 2024 | 21.26 | -2.07 |
EPR Properties Pref E | EPR-E | Oct 31, 2024 | 29.95 | +0.23 |
EPR Properties Pref G | EPR-G | Oct 31, 2024 | 21.91 | -0.61 |
Epsilon Energy | EPSN | Oct 31, 2024 | 5.89 | +1.29 |
EQT | EQT | Oct 31, 2024 | 36.54 | -5.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.